Amber Kovach Counselor Medicare: Medicare Enrolled Practice Location: 8290 Matisse St, Champions Gate, FL 33896 Phone: 330-974-5627 |
News Archive
Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.
More than two-thirds of women and almost three-quarters of men receiving care at Veterans Affairs outpatient facilities in 2000 were overweight – a higher percentage than among the general population – according to a new report in the American Journal of Preventive Medicine.
Tufts Medical Center and Tufts University scientists have found exciting, new functions of the protein angiogenin that play a significant role in the regulation of blood cell formation, important in bone marrow transplantation and recovery from radiation-induced bone marrow failure.
ITL Group's global operation will be front and centre at the 69th Annual Scientific Meeting and Clinical Lab, from 29 July to 3 August in San Diego, California, marking its first appearance in 15 years.
Harvard Medical School scientists have identified a new family of proteins that virtually all bacteria use to build and maintain their cell walls.
› Verified 5 days ago